Pnc Financial Services Group, Inc. Crispr Therapeutics Ag Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,740 shares of CRSP stock, worth $194,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,740

Previous 4,344 13.9%

Holding current value

$194,031

Previous $234,000 25.21%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$44.62 - $62.75 $26,950 - $37,901	-604 Reduced 13.9%	3,740 $175,000
Q2 2024 Aug 09, 2024	BUY	$51.17 - $68.18 $614 - $818	12 Added 0.28%	4,344 $234,000
Q1 2024 May 10, 2024	SELL	$60.67 - $89.12 $64,128 - $94,199	-1,057 Reduced 19.61%	4,332 $295,000
Q4 2023 Feb 09, 2024	SELL	$38.62 - $72.18 $54,801 - $102,423	-1,419 Reduced 20.84%	5,389 $337,000
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $189,866 - $246,797	4,183 Added 159.35%	6,808 $309,000
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $4,216 - $6,573	97 Added 3.84%	2,625 $147,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $12,300 - $16,836	-300 Reduced 10.61%	2,528 $114,000
Q4 2022 Feb 10, 2023	SELL	$39.19 - $65.67 $4,937 - $8,274	-126 Reduced 4.27%	2,828 $114,000
Q3 2022 Nov 10, 2022	BUY	$61.1 - $83.78 $7,698 - $10,556	126 Added 4.46%	2,954 $193,000
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $8,127 - $13,880	-188 Reduced 6.23%	2,828 $171,000
Q1 2022 May 12, 2022	SELL	$53.19 - $79.24 $513,868 - $765,537	-9,661 Reduced 76.21%	3,016 $189,000
Q4 2021 Feb 11, 2022	SELL	$70.09 - $111.29 $36,306 - $57,648	-518 Reduced 3.93%	12,677 $960,000
Q3 2021 Nov 05, 2021	BUY	$110.2 - $156.64 $24,133 - $34,304	219 Added 1.69%	13,195 $1.48 Million
Q2 2021 Aug 06, 2021	SELL	$100.84 - $161.89 $46,890 - $75,278	-465 Reduced 3.46%	12,976 $2.1 Million
Q1 2021 May 07, 2021	BUY	$110.72 - $210.04 $92,783 - $176,013	838 Added 6.65%	13,441 $1.64 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $87,876 - $191,072	1,103 Added 9.59%	12,603 $1.93 Million
Q3 2020 Nov 06, 2020	BUY	$78.5 - $100.64 $50,240 - $64,409	640 Added 5.89%	11,500 $961,000
Q2 2020 Aug 07, 2020	SELL	$38.5 - $76.05 $388,850 - $768,105	-10,100 Reduced 48.19%	10,860 $798,000
Q1 2020 May 08, 2020	BUY	$33.68 - $62.53 $13,472 - $25,012	400 Added 1.95%	20,960 $888,000
Q4 2019 Feb 07, 2020	SELL	$36.68 - $73.13 $10,490 - $20,915	-286 Reduced 1.37%	20,560 $1.25 Million
Q3 2019 Nov 08, 2019	SELL	$40.99 - $52.56 $32,792 - $42,048	-800 Reduced 3.7%	20,846 $854,000
Q1 2019 May 10, 2019	BUY	$28.02 - $40.87 $1,681 - $2,452	60 Added 0.28%	21,646 $0
Q4 2018 Feb 08, 2019	BUY	$22.73 - $42.34 $360,679 - $671,851	15,868 Added 277.51%	21,586 $616,000
Q3 2018 Nov 09, 2018	SELL	$44.35 - $65.71 $185,205 - $274,404	-4,176 Reduced 42.21%	5,718 $0
Q2 2018 Aug 10, 2018	BUY	$42.62 - $73.59 $421,682 - $728,099	9,894 New	9,894 $0

Others Institutions Holding CRSP

# of Institutions

499

Shares Held

56.8M

Call Options Held

1.7M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Crispr Therapeutics Ag Transaction History